spracticeХирургическая практикаSurgical practice (Russia)2223-2427АНО "Консорциум "Медицинская техника"10.17238/issn2223-2427.2019.2.5-10spractice-114Research ArticleСтатьиРЕЗУЛЬТАТЫ ПРИМЕНЕНИЯ БЕССТЕПЛЕРНОГО МИНИ-ГАСТРОШУНТИРОВАНИЯ В ЛЕЧЕНИИ МЕТАБОЛИЧЕСКОГО СИНДРОМА: РАНДОМИЗИРОВАННОЕ КЛИНИЧЕСКОЕ ИССЛЕДОВАНИЕRESULTS OF USING STAPLELESS MINI-GASTRIC BYPASS FOR THE TREATMENT OF THE METABOLIC SYNDROMEhttps://orcid.org/0000-0002-1840-114XОспановО. Б.OspanovO. B.

Оспанов Орал Базарбаевич, доктор медицинских наук, профессор. eLibrary SPIN: 9940-6026Z05K7B9, Нур-Султан, улица Сыганак дом 5/1б кв. 48телефон: +77015287734

Oral B. Ospanov, MD, PhD, ProfessorSyganak str., 5/1, rv.48, Z05K7B9, Nur-Sultan

o_ospanov@mail.ruhttps://orcid.org/0000-0001-5916-2897ЕлеуовГ. А.EleuovG. A.

Елеуов Галымжан Алмасбекович, кандидат медицинских наук

Galymgan A. Eleuov, MD, PhD

g.eleuov@mail.ruhttps://orcid.org/0000-0002-6634-5728БекмурзиноваФ. К.BekmurzinovaF. K.

Бекмурзинова Фарида Кайратовна, студенткаeLilbrary SPIN: 7214-9199644036, Омск, ул. Мельничная д.58В8(913) 646- 68-36

Farida K. Bekmurzinova, bachelor58V Melnichnaya street, 644036 Omsk

farida.bariatric@gmail.comМедицинский университет «Астана»; Корпоративный фонд “University Medical Center”КазахстанAstana Medical University; University Medical CenterKazakhstanКорпоративный фонд “University Medical Center”КазахстанUniversity Medical CenterKazakhstan20191704202002510Copyright © Оспанов О.Б., Елеуов Г.А., Бекмурзинова Ф.К., 20202020Оспанов О.Б., Елеуов Г.А., Бекмурзинова Ф.К.Ospanov O.B., Eleuov G.A., Bekmurzinova F.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.spractice.ru/jour/article/view/114

В представленной статье впервые описывается оценка эффективности разработанного бесстеплерного метода мини-гастрошунтирования по сравнению со стандартным степлерным методом для лечения метаболического синдрома. В результате применения установлено, что авторская и стандартная методики гастрошунтирования в одинаковой степени положительно влияют на устранение основных проявлений метаболического синдрома.

In the present article, after assessment of the effectiveness of the developed stapleless mini-gastric bypass was described on equally effective of the stapleless and standard stapler methods of treating the metabolic syndrome

ожирениеметаболический синдромбариатрическая хирургиялапароскопическое гастрошунтированиебесстеплерное гастрошунтированиеReferencesBenraouane F., Litwin S.E. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol, 2011, 26(6), pp. 555–561. doi:10.1097/HCO.0b013e32834b7fc4Benraouane F., Litwin S.E. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol, 2011, 26(6), pp. 555–561. doi:10.1097/HCO.0b013e32834b7fc4Sjöström L., Narbro K., Sjöström C. The Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med, 2007, 357, pp. 741-752.Sjöström L., Narbro K., Sjöström C. The Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med, 2007, 357, pp. 741-752.Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol, 2014, 20(41), pp. 15135–15143. doi:10.3748/wjg.v20.i41.15135Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol, 2014, 20(41), pp. 15135–15143. doi:10.3748/wjg.v20.i41.15135Ospanov O.B. OBES SURG, 2016, 26, p. 2268. https://doi.org/10.1007/s11695-016-2281-2.Ospanov O.B. OBES SURG, 2016, 26, p. 2268. https://doi.org/10.1007/s11695-016-2281-2.Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006 May, 23(5), pp. 469-80. Review. PubMed PMID: 16681555.Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006 May, 23(5), pp. 469-80. Review. PubMed PMID: 16681555.Carbajo M., García-Caballero M., Toledano M. et al. OBES SURG,2005,15,p.398. https://doi.org/10.1381/0960892053576677Carbajo M., García-Caballero M., Toledano M. et al. OBES SURG,2005,15,p.398. https://doi.org/10.1381/0960892053576677Barzin M., Khalaj A., Motamedi M.A., Shapoori P., Azizi F., Hosseinpanah F. Safety and effectiveness of sleeve gastrectomy versus gastric bypass: one-year results of Tehran Obesity Treatment Study (TOTS). Gastroenterol Hepatol Bed Bench, 2016, 9(Suppl1), pp. S62–S69.Barzin M., Khalaj A., Motamedi M.A., Shapoori P., Azizi F., Hosseinpanah F. Safety and effectiveness of sleeve gastrectomy versus gastric bypass: one-year results of Tehran Obesity Treatment Study (TOTS). Gastroenterol Hepatol Bed Bench, 2016, 9(Suppl1), pp. S62–S69.Kraljević M., Delko T., Köstler T. et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial. Trials, 2017, 18(1), p. 226. doi:10.1186/s13063-017-1957-9.Kraljević M., Delko T., Köstler T. et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial. Trials, 2017, 18(1), p. 226. doi:10.1186/s13063-017-1957-9.Rubino F., Schauer P.R., Kaplan L.M., Cummings D.E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med, 2010, 61, pp. 393-411. doi: 10.1146/annurev.med.051308.105148. Review. PubMed PMID: 20059345.Rubino F., Schauer P.R., Kaplan L.M., Cummings D.E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med, 2010, 61, pp. 393-411. doi: 10.1146/annurev.med.051308.105148. Review. PubMed PMID: 20059345.Adam S., Liu Y., Siahmansur T., Ho J.H., Dhage S.S., Yadav R., New J.P., Donn R., Ammori B.J., Syed A.A., Malik R.A., Soran H., Durrington P.N. Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6. Diab Vasc Dis Res, 2019 Mar, 16(2), pp. 144-152. doi: 10.1177/1479164119826479. PubMed PMID: 31014098.Adam S., Liu Y., Siahmansur T., Ho J.H., Dhage S.S., Yadav R., New J.P., Donn R., Ammori B.J., Syed A.A., Malik R.A., Soran H., Durrington P.N. Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6. Diab Vasc Dis Res, 2019 Mar, 16(2), pp. 144-152. doi: 10.1177/1479164119826479. PubMed PMID: 31014098.Brethauer Stacy A. et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surgery for Obesity and Related Diseases , Volume 11 , Issue 3 , pp. 489 – 506. DOI: https://doi.org/10.1016/j.soard.2015.02.003.Brethauer Stacy A. et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surgery for Obesity and Related Diseases , Volume 11 , Issue 3 , pp. 489 – 506. DOI: https://doi.org/10.1016/j.soard.2015.02.003.Schiavon C.A., Bersch-Ferreira A.C., Santucci E.V. et al. Effects of Bariatric Surgery in Obese Patients with Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018, 137(11), pp. 1132–1142. doi:10.1161/CIRCULATIONAHA.117.032130.Schiavon C.A., Bersch-Ferreira A.C., Santucci E.V. et al. Effects of Bariatric Surgery in Obese Patients with Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018, 137(11), pp. 1132–1142. doi:10.1161/CIRCULATIONAHA.117.032130.Harchaoui K.E., Visser M.E., Kastelein J.J., Stroes E.S., Dallinga-Thie G.M. Triglycerides and cardiovascular risk. Curr Cardiol Rev. 2009, 5(3), pp. 216–222. doi:10.2174/157340309788970315.Harchaoui K.E., Visser M.E., Kastelein J.J., Stroes E.S., Dallinga-Thie G.M. Triglycerides and cardiovascular risk. Curr Cardiol Rev. 2009, 5(3), pp. 216–222. doi:10.2174/157340309788970315.Hokanson John E., Melissa A. Austin. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. Journal of cardiovascular risk, 1996, pp. 213-219.Hokanson John E., Melissa A. Austin. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. Journal of cardiovascular risk, 1996, pp. 213-219.Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet, 2014 Mar, 15, 383(9921), pp. 970-83. doi: 10.1016/S0140-6736(13)61836-X. PubMed PMID: 24269108; PubMed Central PMCID: PMC3959199.Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet, 2014 Mar, 15, 383(9921), pp. 970-83. doi: 10.1016/S0140-6736(13)61836-X. PubMed PMID: 24269108; PubMed Central PMCID: PMC3959199.

The authors declare that there are no conflicts of interest present.